Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, June, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: consultation
2011
PHARMAC documents that matched your search:
Proposal to list Douglas Pharmaceuticals Ltd's brand of acitretin, Novaretin; Closing Date: Closed; Contact: Greg Williams
(2 pages, 113 KB)
2011/07/25
25 July 2011 Proposal to list Douglas Pharmaceuticals Ltd’s brand of acitretin, Novatretin PHARMAC is seeking feedback on a proposal to fund a new brand of acitretin capsules (Novatretin) from 1 October 2011 through a provisional agreement with Douglas Pharmaceuticals…
Proposal for budesonide 3mg capsules; Closing Date: Closed; Contact: Natalie Davis
(3 pages, 126 KB)
2011/07/20
20 July 2011 Proposal to widen access to Budesonide 3 mg capsules PHARMAC is seeking feedback on a proposal to widen access to budesonide 3 mg capsules (Entocort CIR) as follows: Extension of Initial criteria to include approvals for…
2011/12 DRAFT Invitation to Tender
(75 pages, 330 KB)
2011/07/11
QQ November 2011 Dear Supplier INVITATION TO TENDER – SUPPLY OF PHARMACEUTICALS TO DHB HOSPITALS AND/OR TO COMMUNITY PHARMACIES PHARMAC invites tenders for the supply of certain pharmaceuticals to DHB hospitals and/or to community pharmacies in New Zealand. This invitation…
2011/12 Tender Consultation - Medical Groups
(23 pages, 236 KB)
2011/07/11
11 July 2011 2011/12 Multi-product Tender PHARMAC is seeking feedback from medical groups, DHB hospital pharmacies and other interested parties on: A proposal to tender certain pharmaceuticals for sole supply; and The draft process and terms and conditions…
2011/12 Tender Consultation - Suppliers
(24 pages, 265 KB)
2011/07/11
11 July 2011 2011/12 Invitation to Tender PHARMAC is seeking feedback from pharmaceutical suppliers and interested parties on: A proposal to tender certain pharmaceuticals for sole supply; The draft process and terms and conditions for the 2011/12…
Proposal to amend access to adalimumab and etanercept; Closing Date: Closed; Contact: Geraldine MacGibbon
(5 pages, 129 KB)
2011/07/11
11 July 2011 Proposal to amend access to adalimumab and etanercept PHARMAC is seeking feedback on a proposal to amend the Special Authority criteria applying to adalimumab and etanercept for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, and to amend…
Proposal relating to haemophilia treatments; Closing Date: Closed; Contact: Andrew Davies
(4 pages, 110 KB)
2011/06/27
27 June 2011 Proposals to amend the terms of listing of haemophilia treatments in the Pharmaceutical Schedule PHARMAC is seeking feedback on three proposals to amend the listing of recombinant factor VIII, Factor IX and Factor Eight Inhibitors Bypass Agent…
Proposal to amend the listing of mometasone furoate lotion; Closing Date: Closed; Contact: Greg Williams
(1 page, 109 KB)
2011/06/27
27 June 2011 Proposal to amend the listing of mometasone furoate lotion PHARMAC is seeking feedback on a proposal to amend the listing of mometasone furoate (Elocon) Lotion in the Pharmaceutical Schedule through a provisional agreement with Merck Sharp and…
Proposal to widen access to losartan; Closing Date: Closed; Contact: Stephen Woodruffe
(1 page, 106 KB)
2011/06/01
1 June 2011 Proposal to widen access to losartan PHARMAC is seeking feedback on a proposal to remove the Special Authority restrictions that currently apply to losartan and losartan with hydrochlorothiazide from 1 December 2011. Feedback sought PHARMAC welcomes feedback…
Proposal to fund rituximab for patients with CLL; Closing Date: Closed; Contact: Jackie Evans
(5 pages, 139 KB)
2011/05/26
26 May 2011 Proposal to fund rituximab for Chronic Lymphocytic Leukaemia (CLL) PHARMAC is seeking feedback on a proposal to widen access to rituximab (Mabthera) from 1 August 2011 to include funding for patients with Chronic Lymphocytic Leukemia (CLL) through…
